Nexosome Oncology
Novel Diagnostic Proteomics Platform for Cancer
7 employees · est. 2021 · Durham, United States
Sola Diagnostics GmbH
The WID®-easy Test - Now also available in Switzerland 🇨🇭 👉 Unnecessary hysteroscopy and curettage can be avoided
2 employees · est. 2020 · Innsbruck, Austria
Sola Diagnostics GmbH is the older company (2021 vs 2020).
Side-by-Side Comparison
| Metric | Nexosome Oncology | Sola Diagnostics GmbH |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2020 older |
| Headquarters | ||
| Headquarters | Durham, United States | Innsbruck, Austria |
| Employees | ||
| Employees | 7 | 2 |
| Industry | ||
| Industry | Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | Seed |
| Total Funding | ||
| Total Funding | $3.65M | $2.39M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Not tracked yet | Developing and providing epigenetic diagnostic tests for gynecological cancer detection |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients, healthcare providers, and laboratories |
| Taxonomy | ||
| Taxonomy | Diagnostics, Proteomics, Exosome-based Diagnostics, Cancer Detection, Biomarker Discovery, Oncology Research, Precision Medicine, Biosensing Technology, Cancer Diagnostics, Healthcare Innovation | Women's Health Diagnostics, Epigenetic Testing, Gynecological Diagnostics, DNA Methylation, PCR-based Analysis, Clinical Validation, First-line Diagnostic, Non-invasive Testing, Cancer Detection, Startup Expansion, Private Equity Investment |
| Website | ||
| Website | nexosome-oncology.com | sola-diagnostics.com |
About Nexosome Oncology
Nexosome Oncology is a Durham, NC-based health care startup that was founded in 2021. The company's slogan, "Novel Diagnostic Proteomics Platform for Cancer," encapsulates its core mission. As of 22 November 2021, Nexosome Oncology successfully secured a $3.65M Seed Round investment, with Keyhorse C...
About Sola Diagnostics GmbH
Sola Diagnostics GmbH is a biotechnology and healthcare startup which is the home of the WID®-Test. Founded in 2020 and headquartered in Austria, the company has recently secured a €400.00K Seed Round investment from FPS-Holding on 20 February 2025. Their slogan "The WID®-easy Test - Now also availa...
We will tell you when either one moves
BounceWatch watches Nexosome Oncology and Sola Diagnostics GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Nexosome Oncology and Sola Diagnostics GmbH — by email.
Frequently Asked Questions
Compare Nexosome Oncology with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Nexosome Oncology on 12 Sep 2024, and Sola Diagnostics GmbH on 13 Apr 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
